|
US5508269A
(en)
|
1994-10-19 |
1996-04-16 |
Pathogenesis Corporation |
Aminoglycoside formulation for aerosolization
|
|
US6083922A
(en)
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
|
US5767068A
(en)
|
1997-02-13 |
1998-06-16 |
Pathogenesis Corporation |
Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
|
|
DK1385870T3
(da)
*
|
2000-07-21 |
2010-07-05 |
Schering Corp |
Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus
|
|
EP1628674A2
(en)
|
2003-05-06 |
2006-03-01 |
Cytovia, Inc. |
Protease inhibitors for coronaviruses and sars-cov and the use thereof
|
|
ATE382686T1
(de)
|
2003-05-13 |
2008-01-15 |
Univ Luebeck |
Kristallstruktur von der humanen coronavirus 229e hauptproteinase und deren verwendung zur entwicklung von sars-inhibitoren
|
|
US20060014821A1
(en)
*
|
2003-08-27 |
2006-01-19 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of SARS 3C like protease
|
|
US7462594B2
(en)
|
2003-12-31 |
2008-12-09 |
Taigen Biotechnology Co., Ltd. |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
|
|
WO2005113580A1
(en)
|
2004-05-21 |
2005-12-01 |
Pfizer Inc. |
Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
WO2006061714A2
(en)
|
2004-12-09 |
2006-06-15 |
Pfizer Inc. |
Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
|
|
EP1783228A1
(en)
|
2005-11-08 |
2007-05-09 |
ETH Zürich |
Recombinant expression of multiprotein complexes using polygenes
|
|
ES2514316T3
(es)
|
2005-11-22 |
2014-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Partículas similares a virus (VLPs) de Norovirus y Sapovirus
|
|
SG175602A1
(en)
|
2006-07-05 |
2011-11-28 |
Catalyst Biosciences Inc |
Protease screening methods and proteases identified thereby
|
|
WO2010141801A2
(en)
|
2009-06-05 |
2010-12-09 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematophietic cells
|
|
US9008723B2
(en)
*
|
2010-01-08 |
2015-04-14 |
United States Foundation For Inspiration And Recognition Of Science And Technology |
Wireless adapter
|
|
WO2011159684A2
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
CA2850003C
(en)
|
2011-09-27 |
2020-01-07 |
Kansas State University Research Foundation |
Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
|
|
CA2858613A1
(en)
|
2011-12-29 |
2013-08-08 |
Atyr Pharma, Inc. |
Aspartyl-trna synthetase-fc conjugates
|
|
US9828342B2
(en)
|
2012-02-24 |
2017-11-28 |
City Of Hope |
Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereof
|
|
EP2844249A4
(en)
|
2012-05-02 |
2016-03-09 |
Univ Kansas State |
MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS VIRUZIDES AGAINST 3C OR 3C LIKE PROTEASES OF PICORNIVERS, CALICIVIRES AND CORONA VIRUSES
|
|
WO2014040129A1
(en)
|
2012-09-12 |
2014-03-20 |
The University Of Queensland |
Protease-based biosensor
|
|
BR112015016651A2
(pt)
|
2013-01-11 |
2017-07-11 |
Impossible Foods Inc |
réplica de queijo não láctea compreendendo um coacervado
|
|
US20160068820A9
(en)
|
2013-02-08 |
2016-03-10 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Novel Nylanderia Pubens Virus
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
EP3925618A1
(en)
|
2013-07-29 |
2021-12-22 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
EP3044322A4
(en)
|
2013-09-12 |
2017-09-06 |
The University Of Queensland |
Bimolecular protease-based biosensor
|
|
GB201320351D0
(en)
|
2013-11-18 |
2014-01-01 |
Erasmus Universiteit Medisch Ct |
Method
|
|
PL3134432T3
(pl)
|
2014-04-25 |
2020-10-19 |
Bluebird Bio, Inc. |
Promotor mnd chimeryczne receptory antygenowe
|
|
US10023879B2
(en)
|
2014-06-04 |
2018-07-17 |
Fate Therapeutics, Inc. |
Minimal volume reprogramming of mononuclear cells
|
|
SI3151672T1
(sl)
|
2014-06-06 |
2021-03-31 |
Bluebird Bio, Inc. |
Izboljšani T-celični sestavki
|
|
US10017463B2
(en)
|
2014-07-21 |
2018-07-10 |
Brandeis University |
Inhibitors of deubiquitinating proteases
|
|
GB201413020D0
(en)
|
2014-07-23 |
2014-09-03 |
Pribright The Inst |
Coronavirus
|
|
US9328147B2
(en)
|
2014-09-05 |
2016-05-03 |
Chung Yuan Christian University |
Recombinant baculovirus vector and uses thereof
|
|
HRP20191873T1
(hr)
|
2014-12-12 |
2020-01-24 |
Bluebird Bio, Inc. |
Kimerni antigenski receptori
|
|
WO2016138421A1
(en)
|
2015-02-27 |
2016-09-01 |
Iowa State University Research Foundation, Inc. |
Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
|
|
US10784994B2
(en)
|
2015-08-21 |
2020-09-22 |
Lg Electronics Inc. |
Method for transmitting information for LTE-WLAN aggregation system and a device therefor
|
|
WO2017044507A2
(en)
|
2015-09-08 |
2017-03-16 |
Sirnaomics, Inc. |
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
|
|
EP3426674A4
(en)
|
2016-03-09 |
2019-08-14 |
Blade Therapeutics, Inc. |
CYCLIC KETO AMID COMPOUNDS AS CALPAIN MODULATORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
US9975885B2
(en)
|
2016-04-28 |
2018-05-22 |
Purdue Research Foundation |
Broad-spectrum non-covalent coronavirus protease inhibitors
|
|
US11021513B2
(en)
|
2016-05-13 |
2021-06-01 |
Emory University |
Peptidomimetics for the treatment of norovirus infection
|
|
WO2017222935A1
(en)
|
2016-06-20 |
2017-12-28 |
Kansas State University Research Foundation |
Small molecule therapeutic inhibitors against picornaviruses, caliciviruses, and coronaviruses
|
|
WO2018023054A1
(en)
|
2016-07-28 |
2018-02-01 |
Kansas State University Research Foundation |
Protease transition state inhibitor prodrugs
|
|
TW201817714A
(zh)
|
2016-08-30 |
2018-05-16 |
英商葛蘭素史密斯克藍智慧財產權有限公司 |
抑制3c及3cl蛋白酶之化合物及其使用方法
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
MA48797A
(fr)
|
2017-05-25 |
2020-04-08 |
Bluebird Bio Inc |
Variants de l'endonucléase cblb , compositions et procédés d'utilisation
|
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
|
BR112021024310A2
(pt)
|
2019-06-05 |
2022-02-15 |
Univ Emory |
Peptidomiméticos para o tratamento de infecções por coronavírus e picornavírus
|
|
US11045546B1
(en)
|
2020-03-30 |
2021-06-29 |
Cytodyn Inc. |
Methods of treating coronavirus infection
|
|
WO2021205296A1
(en)
|
2020-04-05 |
2021-10-14 |
Pfizer Inc. |
Method of treating covid-19
|
|
WO2021207409A2
(en)
|
2020-04-08 |
2021-10-14 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
|
|
AU2021254045A1
(en)
|
2020-04-10 |
2022-10-13 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
|
WO2021206877A1
(en)
|
2020-04-10 |
2021-10-14 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
|
US11124497B1
(en)
|
2020-04-17 |
2021-09-21 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
EP4146267A1
(en)
*
|
2020-05-08 |
2023-03-15 |
The Board of Trustees of the Leland Stanford Junior University |
Protease inhibitors for treatment or prevention of coronavirus disease
|
|
US11174231B1
(en)
|
2020-06-09 |
2021-11-16 |
Pardes Biosciences, Inc. |
Inhibitors of cysteine proteases and methods of use thereof
|
|
BR112021023814A2
(pt)
*
|
2020-06-09 |
2022-12-20 |
Pardes Biosciences Inc |
Inibidores de proteases de cisteína e métodos de uso das mesmas
|
|
PH12022553378A1
(en)
*
|
2020-06-10 |
2024-03-25 |
Univ Leuven Kath |
Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
|
|
JP2023533016A
(ja)
*
|
2020-07-11 |
2023-08-01 |
ファイザー・インク |
抗ウイルス性ヘテロアリールケトン誘導体
|
|
WO2022020711A1
(en)
|
2020-07-24 |
2022-01-27 |
The Texas A&M University System |
Sars-cov-2 main protease inhibitors
|
|
US10959969B1
(en)
|
2020-07-24 |
2021-03-30 |
Lanny L Johnson |
Methods of treating SARS Cov-2 virus with protocatechuic acid
|
|
CN115960088B
(zh)
*
|
2020-07-31 |
2024-07-26 |
四川大学 |
一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途
|
|
US11351149B2
(en)
*
|
2020-09-03 |
2022-06-07 |
Pfizer Inc. |
Nitrile-containing antiviral compounds
|
|
RS66213B1
(sr)
*
|
2021-04-16 |
2024-12-31 |
Fujian Akeylink Biotechnology Co Ltd |
Jedinjenje kratkog peptida prolina modifikovanog prstenom i upotreba istog
|
|
WO2022251615A1
(en)
*
|
2021-05-28 |
2022-12-01 |
Arun K Ghosh |
Compounds for the treatment of sars
|
|
WO2022256434A1
(en)
*
|
2021-06-02 |
2022-12-08 |
ACEA Therapeutics, Inc. |
Protease inhibitors as antivirals
|
|
EP4159211A4
(en)
*
|
2021-07-15 |
2024-10-30 |
National Center for Global Health and Medicine |
ASSOCIATED WITH PHYSIOLOGICAL ACTIVITY SUCH AS ANTIVIRAL ACTIVITY
|